Vantis Vascular, Inc. is a San Jose, California medical device company founded by interventional cardiologists to build performance-driven tools for complex vascular interventions. Its flagship CrossFAST Integrated Microcatheter Guide Extension System — a dual-monorail advanced delivery system cleared by the FDA under 510(k) and in commercial use since 2025 — is designed to improve deliverability and control in complex, calcified coronary and peripheral anatomy, and a CrossSHOCK intravascular lithotripsy (IVL) system is in development. The company has raised roughly $30M across seed and Series B rounds. It builds and sells physical single-use interventional devices to hospitals and interventionalists; it is not a software vendor and publishes no public API, SDK, developer portal or machine-readable contract of any kind.
Vantis Vascular is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Cardiovascular, and Interventional Cardiology.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: vantis-vascular
name: Vantis Vascular
description: Vantis Vascular, Inc. is a San Jose, California medical device company founded by interventional cardiologists
to build performance-driven tools for complex vascular interventions. Its flagship CrossFAST Integrated Microcatheter Guide
Extension System — a dual-monorail advanced delivery system cleared by the FDA under 510(k) and in commercial use since
2025 — is designed to improve deliverability and control in complex, calcified coronary and peripheral anatomy, and a CrossSHOCK
intravascular lithotripsy (IVL) system is in development. The company has raised roughly $30M across seed and Series B rounds.
It builds and sells physical single-use interventional devices to hospitals and interventionalists; it is not a software
vendor and publishes no public API, SDK, developer portal or machine-readable contract of any kind.
url: https://raw.githubusercontent.com/api-evangelist/vantis-vascular/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-02'
modified: '2026-09-02'
tags:
- Company
- Medical Devices
- Healthcare
- Cardiovascular
- Interventional Cardiology
- Vascular
- Catheters
- Medical Technology
tags_raw:
- Company
- Medical Devices
- Health Care
- Cardiovascular
- Interventional Cardiology
- Vascular
- Catheters
- Medical Technology
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/vantis-vascular-domain-security.yml
- type: Website
url: https://vantisvascular.com/
- type: PrivacyPolicy
url: https://vantisvascular.com/privacy-policy/
- type: LinkedIn
url: https://www.linkedin.com/company/vantis-vascular
x-enrichment:
date: '2026-09-02'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Vantis Vascular manufactures single-use interventional catheters — the FDA 510(k)-cleared CrossFAST guide extension
system and the in-development CrossSHOCK IVL system — and its only web property is a stock WordPress marketing site (the
default "Hello world!" post is still published) whose every path, including a negative-control path that cannot exist,
answers HTTP 202 behind a SiteGround captcha challenge; no api/developer/docs/portal/app/mcp subdomain resolves and no
GitHub organization exists.
evidence:
- url: https://vantisvascular.com/
status: 202
- url: https://vantisvascular.com/.well-known/api-catalog
status: 202
- url: https://vantisvascular.com/.well-known/vantis-vascular-negative-control-7f3ab91c.json
status: 202
- url: https://vantisvascular.com/openapi.json
status: 202
- url: https://api.github.com/orgs/vantisvascular
status: 404
checked: '2026-09-02'
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.